Merck has been accused of withholding information regarding the serious nature of certain Fosamax side effects, notably the drug's propensity towards causing the development of osteonecrosis of the jaw. (yourlegalguide.com)
The radiologists reported new osteonecrosis in 22 - 24 percent of hip injection patients, compared to 5 - 9 percent in the hip control group and 5 percent in the shoulder injection control group. (sciencedaily.com)
More Blog Posts: Novartis Ordered to Pay $ 10.45 M Drug Injury Award to Woman Who Developed Jawbone Damage After Taking Zometa, Drug Injury, November 7, 2012 Fosamax Lawsuit: Merck and Estate of Woman Who Suffered from Osteonecrosis of the Jaw Reach Confidential Damage Award Agreement, Drug Injury Lawyers Blog, October 17, 2012 New FDA Report Suggests Exercising Caution About Using Fosamax Long - Term, Boston Injury Lawyer Blog, May 11, 2012 (druginjurylawyersblog.com)